To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs.
Summary
HR3419 is an early-stage bill reauthorizing telehealth grant programs that has passed the House but stalled in the Senate with no appropriation attached. There is zero guaranteed funding and no direct market impact until an appropriations bill funds these grants.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR3419 authorizes $42.05M/year for telehealth grants through FY2030 but appropriates zero dollars — no funding is guaranteed.
- 2.The bill is stuck in the Senate after House passage; limited cosponsor support (1 cosponsor) suggests low momentum.
- 3.No direct market impact exists until an appropriations bill funds these grants — no tickers to trade on.
Market Implications
No market implications at this stage. The bill is purely procedural with no funded mechanism. Investors should monitor whether an appropriations bill attaches funding — only then would telehealth platform vendors like Teladoc Health ($TDOC) or Amwell ($AMWL) potentially benefit from grant-funded network deployments in rural areas. Current status: zero actionable signal.
Full Analysis
HR3419, introduced by Rep. Valadao (R-CA) in May 2025, amends Section 330I(q) of the Public Health Service Act to reauthorize telehealth network and telehealth resource centers grant programs through FY2030 at $42.05 million per year. The bill passed the House unanimously (48-0 committee vote) and was reported with H. Rept. 119-322 in October 2025. However, it currently sits in the Senate after committee referral on April 22, 2026, with no further action. This is an authorization bill only — it sets a spending ceiling but does not appropriate actual money. The $42.05 million per year figure is the authorized maximum; actual disbursement requires a separate appropriations bill. Without that, the grant programs remain unfunded. The bill's sponsor is a junior House member, and there is only one cosponsor, indicating limited legislative momentum. The market impact is currently zero — no actionable tickers can be identified because there is no guaranteed revenue stream for any company. If funded, the grants would flow to healthcare providers and telehealth network operators in rural and underserved areas, potentially benefiting telehealth platform vendors and rural hospital operators, but that scenario requires Congress to pass an appropriations bill, which is uncertain at this stage. The legislative timeline is stalled: the bill must pass the Senate, be signed into law, and then receive appropriated funds — none of which is imminent.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Protecting Health Care and Lowering Costs Act of 2025
DELL FEDERAL SYSTEMS L.P: $602M Department of Veterans Affairs Contract
Consolidated Appropriations Act, 2026
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.